Vectron Biosolutions AS is your expert on developing cost-effective production processes for industrial proteins in E. coli and other bacteria.
We currently offer free feasibility studies where we test a limited set of our expression vector platform to see if it has the potential to be used as a production technology for our clients proteins. This feasibility study takes 2-3 weeks and will give an answer to whether our technology is suited as the production platform for specific proteins.
A positive outcome of the feasibilty study can then initiate a full production process development where the genetics and fermentation conditions are optimized. The resulting bacterial strain and associated protocols for HCDC are then transferred to our clients under a licensing agreement or transferred to one of Vectron's CMO partners for production.